Cyclitols and phosphoinositides. Wells WW, Eisenberg F, eds. New York: Academic Press, Inc., 1978:535-547
Link
NIOSHTIC No.
00091810
Abstract
Uptake and incorporation of myo-inositol (87898) and phosphate (14265442) into squid and mouse nerve fibers were examined. Tritiated myo-inositol and choline (62497) were used as precursors of the polar headgroups of phosphatidylinositol and phosphatidylcholine. Incubation of squid axoplasm with these precursors and with cytidine-diphosphocholine (987780) yielded more incorporation of myo-inositol than choline into lipid. Autoradiography of mouse sciatic nerve demonstrated that inositol was selectively incorporated into lipid in the axoplasm. The distribution of silver grains over the Schwann cell cytoplasm suggested that both choline and myo-inositol lipid syntheses initially occur in this cell. Some of the lipid formed in Schwann cell cytoplasm was transferred into myelin when incorporation periods were lengthened and some of the phosphatidylinositol formed in the axoplasm was transferred to a region overlaying the axolemma. Inorganic phosphate labeled with 33-P was used to characterize further the axon associated lipid metabolism in mouse myelinated fibers. This precursor was incorporated largely into phosphatidylinositol-bisphosphate and protein. Quantitative examination of electron microscope autoradiographs of cross sectioned fibers revealed sites of incorporation localized to junctions where Schwann cell and axon plasma membranes were located. The authors suggest that phosphatidylinositol and protein are phosphorylated at sites in these membranes.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.